Articles tagged with Melanoma
Researchers found that imiquimod cream, used with surgery, can treat lentigo maligna melanoma, a type of skin cancer. This approach may reduce the area needing surgery, manage the cancer, and minimize its recurrence. The study suggests that imiquimod could be an effective treatment option for some patients.
A BUSM study found that using photographs of UV exposure motivates preteens to adopt better sun protection habits, resulting in a 36% lower reported sunburn rate compared to a control group. The UV photographs also helped identify high-risk students who benefited from the intervention.
Research identifies genetic variants in MC1R as associated with increased melanoma risk in people with dark hair. The study found that these variants were more common in those who did not typically burn easily from the sun, suggesting a complex relationship between genetics and melanoma risk.
A survey found that thinner melanomas are more likely to be detected by physicians, while thicker tumors are often self-detected. Physician skin examination and improved public awareness are key targets for new interventions to promote earlier detection.
A UCSF research team has developed a technique to diagnose melanoma by measuring differences in levels of genetic markers, with a success rate higher than 90 percent. The new strategy distinguished between benign and malignant skin lesions, shedding light on difficult-to-diagnose cases.
Researchers at the NIH/National Human Genome Research Institute have discovered a new tumor suppressor gene, MMP-8, that helps prevent melanoma growth. The finding may lead to more individualized cancer treatment strategies and improved outcomes for patients.
A new study found that a genetic variation increases melanoma risk in pre-menopausal women, with over 40% of those under 50 carrying the mutation. This discovery could lead to more effective surveillance and prevention strategies for this deadly skin cancer.
Researchers found that overexpressing SOX9 restores retinoic acid sensitivity in melanomas and stops tumor growth. A combined therapeutic strategy may provide new hope for treating RA-resistant cancers like melanoma.
A new study published in Ophthalmology highlights the association between skin moles and freckles and a higher risk of uveal melanoma, while also reassuring on the low infection rates following cataract surgery. The research found that people with atypical moles are 2.8 times more likely to develop uveal melanoma.
A study of nearly 157,000 people found that those with a family history of melanoma were nearly twice as likely to develop Parkinson's disease. Researchers suggest that the two diseases may share common genetic components.
Researchers discovered that atypical spitzoid tumors (ASTs) respond well to treatment, with 27 patients experiencing complete remission after a lymph node biopsy. The study suggests ASTs behave differently from other types of melanoma and may not be as aggressive.
Researchers examined the link between mobile phone use and uveal melanoma in a large study of 1,453 participants. No significant increased risk was found among regular users or those who used radio sets, suggesting that phone use may not be associated with this type of eye cancer.
A study published in The Lancet predicts John McCain's mortality rate due to melanoma, with a 10-year survival rate of 24%. The author suggests that McCain's risk improves if his cancer has not spread, reducing the annual mortality rate to 6% per year.
A genetic variant in the cyclin D1 gene is associated with a higher risk of developing melanoma. Individuals carrying two copies of the variant are 80% more likely to develop the disease. Extended and escalated dose chemotherapy shows no survival benefit in advanced melanoma cases.
A new study found a cancer gene in swordtail fish is conserved due to its role in attracting female mates. The melanoma gene creates an attractive natural marking that lures females, but the population also keeps the prevalence of the gene in check.
Researchers have developed a prototype test that can predict clinical outcome for melanoma patients, distinguishing between rapid and slow progression to Stage IV cancer. The test uses gene signature analysis and shows promise in identifying patient subtypes, which could improve treatment decisions and reduce clinical trial sizes.
A study by Uppsala University has identified the genetic mutation responsible for white horses' coats and found a link to an increased risk of melanoma. The dominant Greying with age mutation is shared among Grey horses, suggesting a common ancestor lived thousands of years ago.
Researchers have identified a new protein produced excessively in malignant melanoma, which may help distinguish it from benign moles. The discovery offers a potential target for treatment and could improve diagnosis of skin cancer rates rising among young women.
A phase III study found that pegylated interferon alfa-2b significantly improved recurrence-free survival in stage III melanoma patients, with a median treatment duration of one year. The treatment reduced the risk of recurrence by 18% and was associated with serious adverse events such as fatigue, liver toxicity, and depression.
Research by Professor Jillian Birch found that cancer incidence and mortality rates decrease with increasing deprivation among teenagers and young adults. Notably, cervical cancer and melanoma show increasing rates despite being preventable.
A new study published in PLOS Medicine has found that circumcision is safe for both HIV-infected and HIV-uninfected men, with a low risk of moderate or severe surgical complications. The study also highlights the importance of refraining from intercourse after circumcision to prevent transmission of HIV to women partners.
Researchers combined two biotherapies to induce an anti-tumor response, showing a 19% overall response rate in stage 4 melanoma patients. The treatment was found to be tolerable in terms of toxicity.
A pilot study at Duke University Medical Center found that disabling a protein on melanoma cells makes them more vulnerable to chemotherapy, resulting in complete responses in 8 out of 16 patients. The compound ADH-1 was tested in combination with chemotherapy and showed promising results.
Researchers found DNA abnormalities in the KIT gene linked to highly malignant skin cancers, offering hope for effective treatments. The study could lead to targeted therapies within 18 months.
Studies found that mutations in the p14ARF gene can promote melanoma development, even with normal p16 levels. Researchers also discovered an estrogen signaling pathway in aggressive prostate cancer, driving its growth. Additionally, adding paclitaxel to standard chemotherapy improves outcomes in early breast cancer patients.
Regular skin self-exams can help couples detect melanoma earlier, increasing their chances of survival. Couples with strong bonds are more likely to perform these exams and support each other through the process.
A genome-wide study has identified a new gene on chromosome 20 that influences a person's risk of developing melanoma. This finding holds implications for the general population, with the associated genetic variations being found in 16% of people who are at nearly double the increased risk of developing the disease.
A new study suggests that targeting and disabling a protein in melanoma tumors can make them more vulnerable to chemotherapy. Researchers found that combining targeted therapy with melphalan chemotherapy reduced tumor size by up to 30-fold, compared to chemotherapy alone.
A primary anorectal melanoma was reported in a 41-year-old man, presenting with rectal bleeding and polypoid tumor. Histopathology revealed a melanoma, but initial dissemination studies were negative. Unfortunately, metastases developed two years later, leading to the patient's death.
A recent study found that individuals with melanoma on their scalp or neck have lower survival rates than those with melanomas at other sites. The study analyzed data from U.S. cancer registries and found significant differences in five-year and 10-year survival rates, highlighting the importance of skin awareness and sun protection.
Larger skin lesions are more likely to be melanomas than smaller moles, according to a new study by NYU researchers. The study confirms that an important warning sign of melanoma - moles larger than 6 millimeters - is still valid.
Researchers at the University of North Carolina at Chapel Hill have discovered that people with melanoma on their scalp or neck are more likely to die from the disease. The analysis of 51,704 melanoma cases found that survival rates differ depending on where skin cancer first appears.
A study published in Archives of Dermatology found that larger skin lesions (over 6mm) are more likely to be melanoma. The findings support the use of diameter guidelines for screening, but also suggest that smaller lesions can still be malignant.
Higher blood levels of interleukin-12 (IL-12) are associated with poor overall survival in Stage III melanoma patients. Age is also a significant risk factor for death, but only when combined with IL-12 levels.
A study found that melanomas can appear noticeably different from other moles, with 85% of participants identifying them as distinct. The 'ugly duckling' sign may prove a useful screening strategy for primary health care providers and skin self-examination.
Research found that patients traveling farther to reach their physician are more likely to have thicker skin cancer at diagnosis. Longer distances were associated with increased Breslow thickness, and rural locations and lack of dermatologists in the area also contributed to poorer outcomes.
Researchers found that early life sun exposure increases the risk of melanomas with BRAF gene mutations. Patients who reported high levels of sun exposure before age 20 were more likely to have this mutation. In contrast, patients with NRAS gene mutations had higher exposure between ages 50-60.
A Phase II study has shown that combining chemotherapy drugs with an antiangiogenic agent can significantly delay the spread of tumors in patients with metastatic melanoma. The treatment, which included paclitaxel and carboplatin with bevacizumab, prevented tumor growth for almost six months and improved survival rates.
Researchers found that patients with higher levels of protein S-100 in their serum samples had a greater likelihood of melanoma returning after treatment. The study identified S-100 as a potential biomarker for predicting disease recurrence and stratifying patients into those more or less likely to relapse.
A recent study by Frederick H. Davidorf, MD, found that uveal melanoma patients and their families are at higher risk for developing colon cancer. The study involved 130 patients who provided their extended family medical histories, revealing a significant number of patients and relatives with an increased risk for colon cancer.
Research found that individuals with melanoma diagnosed by a dermatologist tend to have thinner tumors, leading to improved five-year survival rates. The study analyzed data from Medicare and cancer databases, comparing outcomes between dermatologist- and non-dermatologist-diagnosed patients.
The online survey aims to learn how people of different nationalities behave while having fun in the sun, and their attitudes to tanning and skin cancer. Researchers have identified four high-risk melanoma genes that increase someone's risk of skin cancer.
A study found that learning skin self-examination with a partner enhances the perceived importance and performance of this critical cancer prevention behavior. Participants who learned together showed stronger intentions to examine their skin regularly, especially in hard-to-see areas like the scalp and back.
A mathematical model suggests that one-time screening of adults age 50 or older for malignant melanoma is very cost-effective, with costs totaling $10,100 per quality-adjusted life year gained. Screening every two years may also be cost-effective, depending on disease progression rates.
A study investigated melanoma growth rate in 404 patients and found that fast-growing melanomas are more likely to occur in elderly men and individuals with fewer moles and freckles. The study provides descriptive data on the spectrum of melanoma rates of growth, offering insights into subgroups associated with rapid growth.
A study found that children who received light therapy (phototherapy) for jaundice as infants had an increased risk of developing skin moles in childhood. The study, published in Archives of Dermatology, examined 58 French children and found a significant association between phototherapy and the number of moles
Researchers discovered a potential strategy for treating metastatic melanoma by combining an antibody with radiation, leveraging insights from studying a fungus that causes infection in people with AIDS. The treatment approach shows promise in inhibiting tumor growth and inducing regression in mice with small melanoma tumors.
A study of marathon runners found that those who ran longer distances and wore inadequate clothing during training were more likely to develop skin cancer. The authors advise runners to reduce UV exposure by choosing low-sun schedules, wearing adequate clothing, and regularly using water-resistant sunscreens.
Studies found that statins and fibrates have uncertain impact on melanoma prevention, while a new virus kills brain cancer cells in mice. An antibody combination shows efficacy in ovarian cancer, while immunohistochemical assays predict breast cancer treatment response better than older methods
A study has identified molecular markers in RNA and DNA that can detect small metastases from ocular melanoma, allowing for early intervention. Fine needle biopsy is a feasible method to accurately detect these markers, enabling clinicians to identify high-risk patients who may benefit from targeted treatments.
Scientists have developed a method to predict whether melanoma of the eye will spread to the liver, where it quickly turns deadly. The molecular screening test can detect both whether a tumor is likely to spread and how fast.
A new study reveals that targeted melanoma education of high-risk groups leads to sustained improvements in skin self-examination rates. The intervention, which included personalized educational materials and counseling sessions, significantly increased the number of siblings who performed regular skin self-examinations.
A community-based education campaign significantly increased skin cancer screening rates in men over 50, with a two-fold increase in self-screening and four-fold increase in physician-screening. Men who recognized personal risk factors or had previously removed skin lesions were more likely to undergo screening.
A review of 1,690 melanoma cases in Miami-Dade County found that Hispanic and black patients were more likely to have advanced-stage melanomas than white patients. This disparity may contribute to lower survival rates among blacks and Hispanics.
Breakthroughs in melanoma research suggest optimism for future cures, with artificial skin models enabling the study of tumor interactions and immune system responses. A novel vaccine approach also shows promise in treating melanoma by stimulating killer T cells to attack cancerous cells.
Researchers found no link between a fatty diet and an increased risk of skin cancer. In fact, patients who had previously been diagnosed with a skin cancer other than melanoma even had a lower risk of getting a further non-melanoma skin cancer if they reported consuming more fat.
A new professorship in melanoma research has been established at the Cross Cancer Institute in Edmonton, Alberta. The endowment fund, valued at $1 million, will support long-term commitment to researching key pathways in melanoma development that could lead to potential targets for prevention and therapy.
A recent study published in Dermatologic Surgery reveals a significant link between summer sun exposure and the development of melanoma. Sun protective measures such as sunscreen and clothing are necessary to prevent skin cancer, despite controversy surrounding current guidelines.
Researchers found that 20% of participants developed additional melanoma within one year and 27% within two years after initial diagnosis. Those with atypical moles had a higher risk of developing additional melanomas, with those having three or more atypical moles being four times more likely to develop multiple tumors.
Researchers found that interferon treatment correlates with signaling proteins STAT1 and STAT3, which can be used as biomarkers to predict melanoma risk. The study suggests that these markers could help identify patients most likely to benefit from specific doses of interferon therapy.